SVP, Pharmaceutical and Nonclinical Development @ Normunity
VP, Pharmaceutical Development and Interim Lead, Non-clinical Development @ Goldfinch Bio
Head, Translational Medicines, Discovery and Pharmaceutical Development Strategy and Operations @ Bristol Myers Squibb
Head, Business Operations, Global Regulatory, Safety and Biometrics @ Bristol Myers Squibb
Executive Director, Strategy and BusinessOperations, Global Manufacturing and Supply @ Bristol Myers Squibb
Executive Director, Pharmaceutical Development Business Operations and CMC Writing @ Bristol Myers Squibb
Director and Associate Director, PD Licensing, Operations and Planning @ Bristol Myers Squibb
Saul Fink's Education
University of Houston
PhD (Chemistry)
Millersville University of Pennsylvania
BS (Chemistry)
Saul Fink's Skills
Strategy
Six Sigma
Performance Management
Leadership
Project Management
Management
Resource Management
Continuous Improvement
Strategic Planning
Outsourcing
Saul Fink's Summary
Saul Fink, based in Cambridge, MA, US, is currently a Chief Technology Officer at Q32 Bio Inc., bringing experience from previous roles at Intrommune Therapeutics, Normunity, Goldfinch Bio and Bristol-Myers Squibb. Saul Fink holds a PhD in Chemistry @ University of Houston. With a robust skill set that includes Strategy, Six Sigma, Performance Management, Leadership, Project Management and more, Saul Fink contributes valuable insights to the industry. Saul Fink has 5 emails and 1 mobile phone number on RocketReach.